APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Spine Osteoarthritis Pain Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Spine Osteoarthritis Pain Drug Market Analysis and Forecast 2026-2032

Report ID 174037430221 December 2025208 pages

Choose your research edition.

Industry ResearchSpine Osteoarthritis Pain Drug Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Spine Osteoarthritis Pain Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Spine Osteoarthritis Pain Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spine Osteoarthritis Pain Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Spine Osteoarthritis Pain Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Spine Osteoarthritis Pain Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Spine Osteoarthritis Pain Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Spine Osteoarthritis Pain Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Spine Osteoarthritis Pain Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Spine Osteoarthritis Pain Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Spine Osteoarthritis Pain Drug include Abbott, TEVA, Sanofi, Johnson and Johnson, Novartis, Mylan, Eli Lilly, Hengrui Pharmaceutical and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Spine Osteoarthritis Pain Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Spine Osteoarthritis Pain Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Spine Osteoarthritis Pain Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Spine Osteoarthritis Pain Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Spine Osteoarthritis Pain Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Spine Osteoarthritis Pain Drug sales, projected growth trends, production technology, application and end-user industry.

Spine Osteoarthritis Pain Drug Segment by Company

Abbott

TEVA

Sanofi

Johnson and Johnson

Novartis

Mylan

Eli Lilly

Hengrui Pharmaceutical

Pfizer

GlaxoSmithKline

Daiichi Sankyo

Bayer

Tide Pharmaceutical

Iroko Pharmaceuticals

Horizon Pharma

Astellas Pharma

Almatica Pharma

Abiogen Pharma

Spine Osteoarthritis Pain Drug Segment by Type

Injection

External

Oral

Spine Osteoarthritis Pain Drug Segment by Application

Medical Care

Personal Care

Spine Osteoarthritis Pain Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spine Osteoarthritis Pain Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spine Osteoarthritis Pain Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spine Osteoarthritis Pain Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Spine Osteoarthritis Pain Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Spine Osteoarthritis Pain Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spine Osteoarthritis Pain Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Spine Osteoarthritis Pain Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. External Major Manufacturers Table 4. Oral Major Manufacturers Table 5. Global Spine Osteoarthritis Pain Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medical Care Major Manufacturers Table 7. Personal Care Major Manufacturers Table 8. Spine Osteoarthritis Pain Drug Industry Trends Table 9. Spine Osteoarthritis Pain Drug Industry Drivers Table 10. Spine Osteoarthritis Pain Drug Industry Opportunities and Challenges Table 11. Spine Osteoarthritis Pain Drug Industry Restraints Table 12. Global Spine Osteoarthritis Pain Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Spine Osteoarthritis Pain Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Spine Osteoarthritis Pain Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Region (2021-2026) Table 16. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Region (2027-2032) Table 17. Global Spine Osteoarthritis Pain Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Spine Osteoarthritis Pain Drug Sales by Region (2021-2026) & (k units) Table 19. Global Spine Osteoarthritis Pain Drug Sales by Region (2027-2032) & (k units) Table 20. Global Spine Osteoarthritis Pain Drug Sales Market Share by Region (2021-2026) Table 21. Global Spine Osteoarthritis Pain Drug Sales Market Share by Region (2027-2032) Table 22. Global Spine Osteoarthritis Pain Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Spine Osteoarthritis Pain Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Spine Osteoarthritis Pain Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Spine Osteoarthritis Pain Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Spine Osteoarthritis Pain Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Spine Osteoarthritis Pain Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Spine Osteoarthritis Pain Drug Manufacturers, Product Type & Application Table 30. Global Spine Osteoarthritis Pain Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Spine Osteoarthritis Pain Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Spine Osteoarthritis Pain Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Spine Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Spine Osteoarthritis Pain Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Type (2021-2026) Table 37. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Type (2027-2032) Table 38. Global Spine Osteoarthritis Pain Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Spine Osteoarthritis Pain Drug Sales by Type (2021-2026) & (k units) Table 40. Global Spine Osteoarthritis Pain Drug Sales by Type (2027-2032) & (k units) Table 41. Global Spine Osteoarthritis Pain Drug Sales Market Share by Type (2021-2026) Table 42. Global Spine Osteoarthritis Pain Drug Sales Market Share by Type (2027-2032) Table 43. Global Spine Osteoarthritis Pain Drug Price by Type (2021-2026) & (US$/unit) Table 44. Global Spine Osteoarthritis Pain Drug Price by Type (2027-2032) & (US$/unit) Table 45. Global Spine Osteoarthritis Pain Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Spine Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Spine Osteoarthritis Pain Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Application (2021-2026) Table 49. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Application (2027-2032) Table 50. Global Spine Osteoarthritis Pain Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Spine Osteoarthritis Pain Drug Sales by Application (2021-2026) & (k units) Table 52. Global Spine Osteoarthritis Pain Drug Sales by Application (2027-2032) & (k units) Table 53. Global Spine Osteoarthritis Pain Drug Sales Market Share by Application (2021-2026) Table 54. Global Spine Osteoarthritis Pain Drug Sales Market Share by Application (2027-2032) Table 55. Global Spine Osteoarthritis Pain Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Spine Osteoarthritis Pain Drug Price by Application (2027-2032) & (US$/unit) Table 57. Abbott Company Information Table 58. Abbott Business Overview Table 59. Abbott Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Abbott Spine Osteoarthritis Pain Drug Product Portfolio Table 61. Abbott Recent Development Table 62. TEVA Company Information Table 63. TEVA Business Overview Table 64. TEVA Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. TEVA Spine Osteoarthritis Pain Drug Product Portfolio Table 66. TEVA Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sanofi Spine Osteoarthritis Pain Drug Product Portfolio Table 71. Sanofi Recent Development Table 72. Johnson and Johnson Company Information Table 73. Johnson and Johnson Business Overview Table 74. Johnson and Johnson Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Johnson and Johnson Spine Osteoarthritis Pain Drug Product Portfolio Table 76. Johnson and Johnson Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Novartis Spine Osteoarthritis Pain Drug Product Portfolio Table 81. Novartis Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Mylan Spine Osteoarthritis Pain Drug Product Portfolio Table 86. Mylan Recent Development Table 87. Eli Lilly Company Information Table 88. Eli Lilly Business Overview Table 89. Eli Lilly Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Eli Lilly Spine Osteoarthritis Pain Drug Product Portfolio Table 91. Eli Lilly Recent Development Table 92. Hengrui Pharmaceutical Company Information Table 93. Hengrui Pharmaceutical Business Overview Table 94. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Product Portfolio Table 96. Hengrui Pharmaceutical Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Pfizer Spine Osteoarthritis Pain Drug Product Portfolio Table 101. Pfizer Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Spine Osteoarthritis Pain Drug Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Daiichi Sankyo Company Information Table 108. Daiichi Sankyo Business Overview Table 109. Daiichi Sankyo Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Daiichi Sankyo Spine Osteoarthritis Pain Drug Product Portfolio Table 111. Daiichi Sankyo Recent Development Table 112. Bayer Company Information Table 113. Bayer Business Overview Table 114. Bayer Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Bayer Spine Osteoarthritis Pain Drug Product Portfolio Table 116. Bayer Recent Development Table 117. Tide Pharmaceutical Company Information Table 118. Tide Pharmaceutical Business Overview Table 119. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Product Portfolio Table 121. Tide Pharmaceutical Recent Development Table 122. Iroko Pharmaceuticals Company Information Table 123. Iroko Pharmaceuticals Business Overview Table 124. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Product Portfolio Table 126. Iroko Pharmaceuticals Recent Development Table 127. Horizon Pharma Company Information Table 128. Horizon Pharma Business Overview Table 129. Horizon Pharma Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Horizon Pharma Spine Osteoarthritis Pain Drug Product Portfolio Table 131. Horizon Pharma Recent Development Table 132. Astellas Pharma Company Information Table 133. Astellas Pharma Business Overview Table 134. Astellas Pharma Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Astellas Pharma Spine Osteoarthritis Pain Drug Product Portfolio Table 136. Astellas Pharma Recent Development Table 137. Almatica Pharma Company Information Table 138. Almatica Pharma Business Overview Table 139. Almatica Pharma Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Almatica Pharma Spine Osteoarthritis Pain Drug Product Portfolio Table 141. Almatica Pharma Recent Development Table 142. Abiogen Pharma Company Information Table 143. Abiogen Pharma Business Overview Table 144. Abiogen Pharma Spine Osteoarthritis Pain Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Abiogen Pharma Spine Osteoarthritis Pain Drug Product Portfolio Table 146. Abiogen Pharma Recent Development Table 147. North America Spine Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Spine Osteoarthritis Pain Drug Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Spine Osteoarthritis Pain Drug Sales by Type (2021-2026) & (k units) Table 150. North America Spine Osteoarthritis Pain Drug Sales by Type (2027-2032) & (k units) Table 151. North America Spine Osteoarthritis Pain Drug Sales Price by Type (2021-2026) & (US$/unit) Table 152. North America Spine Osteoarthritis Pain Drug Sales Price by Type (2027-2032) & (US$/unit) Table 153. North America Spine Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Spine Osteoarthritis Pain Drug Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Spine Osteoarthritis Pain Drug Sales by Application (2021-2026) & (k units) Table 156. North America Spine Osteoarthritis Pain Drug Sales by Application (2027-2032) & (k units) Table 157. North America Spine Osteoarthritis Pain Drug Sales Price by Application (2021-2026) & (US$/unit) Table 158. North America Spine Osteoarthritis Pain Drug Sales Price by Application (2027-2032) & (US$/unit) Table 159. North America Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. North America Spine Osteoarthritis Pain Drug Sales by Country (2021-2026) & (k units) Table 164. North America Spine Osteoarthritis Pain Drug Sales by Country (2027-2032) & (k units) Table 165. North America Spine Osteoarthritis Pain Drug Sales Price by Country (2021-2026) & (US$/unit) Table 166. North America Spine Osteoarthritis Pain Drug Sales Price by Country (2027-2032) & (US$/unit) Table 167. United States Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 168. Canada Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 169. Mexico Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 170. Europe Spine Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Spine Osteoarthritis Pain Drug Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Spine Osteoarthritis Pain Drug Sales by Type (2021-2026) & (k units) Table 173. Europe Spine Osteoarthritis Pain Drug Sales by Type (2027-2032) & (k units) Table 174. Europe Spine Osteoarthritis Pain Drug Sales Price by Type (2021-2026) & (US$/unit) Table 175. Europe Spine Osteoarthritis Pain Drug Sales Price by Type (2027-2032) & (US$/unit) Table 176. Europe Spine Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Spine Osteoarthritis Pain Drug Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Spine Osteoarthritis Pain Drug Sales by Application (2021-2026) & (k units) Table 179. Europe Spine Osteoarthritis Pain Drug Sales by Application (2027-2032) & (k units) Table 180. Europe Spine Osteoarthritis Pain Drug Sales Price by Application (2021-2026) & (US$/unit) Table 181. Europe Spine Osteoarthritis Pain Drug Sales Price by Application (2027-2032) & (US$/unit) Table 182. Europe Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Europe Spine Osteoarthritis Pain Drug Sales by Country (2021-2026) & (k units) Table 187. Europe Spine Osteoarthritis Pain Drug Sales by Country (2027-2032) & (k units) Table 188. Europe Spine Osteoarthritis Pain Drug Sales Price by Country (2021-2026) & (US$/unit) Table 189. Europe Spine Osteoarthritis Pain Drug Sales Price by Country (2027-2032) & (US$/unit) Table 190. Germany Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 191. France Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 192. U.K. Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 193. Italy Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 194. Russia Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 195. Spain Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 198. Sweden Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 199. Poland Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 200. China Spine Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (US$ Million) Table 201. China Spine Osteoarthritis Pain Drug Revenue by Type (2027-2032) & (US$ Million) Table 202. China Spine Osteoarthritis Pain Drug Sales by Type (2021-2026) & (k units) Table 203. China Spine Osteoarthritis Pain Drug Sales by Type (2027-2032) & (k units) Table 204. China Spine Osteoarthritis Pain Drug Sales Price by Type (2021-2026) & (US$/unit) Table 205. China Spine Osteoarthritis Pain Drug Sales Price by Type (2027-2032) & (US$/unit) Table 206. China Spine Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (US$ Million) Table 207. China Spine Osteoarthritis Pain Drug Revenue by Application (2027-2032) & (US$ Million) Table 208. China Spine Osteoarthritis Pain Drug Sales by Application (2021-2026) & (k units) Table 209. China Spine Osteoarthritis Pain Drug Sales by Application (2027-2032) & (k units) Table 210. China Spine Osteoarthritis Pain Drug Sales Price by Application (2021-2026) & (US$/unit) Table 211. China Spine Osteoarthritis Pain Drug Sales Price by Application (2027-2032) & (US$/unit) Table 212. Asia Spine Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Spine Osteoarthritis Pain Drug Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Spine Osteoarthritis Pain Drug Sales by Type (2021-2026) & (k units) Table 215. Asia Spine Osteoarthritis Pain Drug Sales by Type (2027-2032) & (k units) Table 216. Asia Spine Osteoarthritis Pain Drug Sales Price by Type (2021-2026) & (US$/unit) Table 217. Asia Spine Osteoarthritis Pain Drug Sales Price by Type (2027-2032) & (US$/unit) Table 218. Asia Spine Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Spine Osteoarthritis Pain Drug Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Spine Osteoarthritis Pain Drug Sales by Application (2021-2026) & (k units) Table 221. Asia Spine Osteoarthritis Pain Drug Sales by Application (2027-2032) & (k units) Table 222. Asia Spine Osteoarthritis Pain Drug Sales Price by Application (2021-2026) & (US$/unit) Table 223. Asia Spine Osteoarthritis Pain Drug Sales Price by Application (2027-2032) & (US$/unit) Table 224. Asia Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 228. Asia Spine Osteoarthritis Pain Drug Sales by Country (2021-2026) & (k units) Table 229. Asia Spine Osteoarthritis Pain Drug Sales by Country (2027-2032) & (k units) Table 230. Asia Spine Osteoarthritis Pain Drug Sales Price by Country (2021-2026) & (US$/unit) Table 231. Asia Spine Osteoarthritis Pain Drug Sales Price by Country (2027-2032) & (US$/unit) Table 232. Japan Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 233. South Korea Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 234. India Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 235. Australia Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Spine Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Spine Osteoarthritis Pain Drug Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Spine Osteoarthritis Pain Drug Sales by Type (2021-2026) & (k units) Table 241. SAMEA Spine Osteoarthritis Pain Drug Sales by Type (2027-2032) & (k units) Table 242. SAMEA Spine Osteoarthritis Pain Drug Sales Price by Type (2021-2026) & (US$/unit) Table 243. SAMEA Spine Osteoarthritis Pain Drug Sales Price by Type (2027-2032) & (US$/unit) Table 244. SAMEA Spine Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Spine Osteoarthritis Pain Drug Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Spine Osteoarthritis Pain Drug Sales by Application (2021-2026) & (k units) Table 247. SAMEA Spine Osteoarthritis Pain Drug Sales by Application (2027-2032) & (k units) Table 248. SAMEA Spine Osteoarthritis Pain Drug Sales Price by Application (2021-2026) & (US$/unit) Table 249. SAMEA Spine Osteoarthritis Pain Drug Sales Price by Application (2027-2032) & (US$/unit) Table 250. SAMEA Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 254. SAMEA Spine Osteoarthritis Pain Drug Sales by Country (2021-2026) & (k units) Table 255. SAMEA Spine Osteoarthritis Pain Drug Sales by Country (2027-2032) & (k units) Table 256. SAMEA Spine Osteoarthritis Pain Drug Sales Price by Country (2021-2026) & (US$/unit) Table 257. SAMEA Spine Osteoarthritis Pain Drug Sales Price by Country (2027-2032) & (US$/unit) Table 258. Brazil Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 259. Argentina Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 260. Chile Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 261. Colombia Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 262. Peru Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 264. Israel Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 265. UAE Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 266. Turkey Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 267. Iran Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 268. Egypt Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Spine Osteoarthritis Pain Drug Distributors List Table 272. Spine Osteoarthritis Pain Drug Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Spine Osteoarthritis Pain Drug Image Figure 2. Global Spine Osteoarthritis Pain Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spine Osteoarthritis Pain Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. External Image Figure 6. Oral Image Figure 7. Global Spine Osteoarthritis Pain Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Spine Osteoarthritis Pain Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medical Care Image Figure 10. Personal Care Image Figure 11. Global Spine Osteoarthritis Pain Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Spine Osteoarthritis Pain Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Spine Osteoarthritis Pain Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Spine Osteoarthritis Pain Drug Sales (2021-2032) & (k units) Figure 17. Global Spine Osteoarthritis Pain Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Spine Osteoarthritis Pain Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Spine Osteoarthritis Pain Drug Sales YoY (2021-2032) & (k units) Figure 20. Europe Spine Osteoarthritis Pain Drug Sales YoY (2021-2032) & (k units) Figure 21. China Spine Osteoarthritis Pain Drug Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Spine Osteoarthritis Pain Drug Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Spine Osteoarthritis Pain Drug Sales YoY (2021-2032) & (k units) Figure 24. Global Spine Osteoarthritis Pain Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Spine Osteoarthritis Pain Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Spine Osteoarthritis Pain Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Spine Osteoarthritis Pain Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Spine Osteoarthritis Pain Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Spine Osteoarthritis Pain Drug Sales Market Share by Type (2021-2032) Figure 33. Global Spine Osteoarthritis Pain Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Spine Osteoarthritis Pain Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Spine Osteoarthritis Pain Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Spine Osteoarthritis Pain Drug Sales Market Share by Application (2021-2032) Figure 39. North America Spine Osteoarthritis Pain Drug Revenue Share by Type (2021-2032) Figure 40. North America Spine Osteoarthritis Pain Drug Sales Share by Type (2021-2032) Figure 41. North America Spine Osteoarthritis Pain Drug Revenue Share by Application (2021-2032) Figure 42. North America Spine Osteoarthritis Pain Drug Sales Share by Application (2021-2032) Figure 43. North America Spine Osteoarthritis Pain Drug Revenue Share by Country (2021-2032) Figure 44. North America Spine Osteoarthritis Pain Drug Sales Share by Country (2021-2032) Figure 45. Europe Spine Osteoarthritis Pain Drug Revenue Share by Type (2021-2032) Figure 46. Europe Spine Osteoarthritis Pain Drug Sales Share by Type (2021-2032) Figure 47. Europe Spine Osteoarthritis Pain Drug Revenue Share by Application (2021-2032) Figure 48. Europe Spine Osteoarthritis Pain Drug Sales Share by Application (2021-2032) Figure 49. Europe Spine Osteoarthritis Pain Drug Revenue Share by Country (2021-2032) Figure 50. Europe Spine Osteoarthritis Pain Drug Sales Share by Country (2021-2032) Figure 51. China Spine Osteoarthritis Pain Drug Revenue Share by Type (2021-2032) Figure 52. China Spine Osteoarthritis Pain Drug Sales Share by Type (2021-2032) Figure 53. China Spine Osteoarthritis Pain Drug Revenue Share by Application (2021-2032) Figure 54. China Spine Osteoarthritis Pain Drug Sales Share by Application (2021-2032) Figure 55. Asia Spine Osteoarthritis Pain Drug Revenue Share by Type (2021-2032) Figure 56. Asia Spine Osteoarthritis Pain Drug Sales Share by Type (2021-2032) Figure 57. Asia Spine Osteoarthritis Pain Drug Revenue Share by Application (2021-2032) Figure 58. Asia Spine Osteoarthritis Pain Drug Sales Share by Application (2021-2032) Figure 59. Asia Spine Osteoarthritis Pain Drug Revenue Share by Country (2021-2032) Figure 60. Asia Spine Osteoarthritis Pain Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Spine Osteoarthritis Pain Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Spine Osteoarthritis Pain Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Spine Osteoarthritis Pain Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Spine Osteoarthritis Pain Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Spine Osteoarthritis Pain Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Spine Osteoarthritis Pain Drug Sales Share by Country (2021-2032) Figure 67. Spine Osteoarthritis Pain Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Spine Osteoarthritis Pain Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • External
  • Oral
Applications
  • Medical Care
  • Personal Care
Companies covered
  • Abbott
  • TEVA
  • Sanofi
  • Johnson and Johnson
  • Novartis
  • Mylan
  • Eli Lilly
  • Hengrui Pharmaceutical
  • Pfizer
  • GlaxoSmithKline
  • Daiichi Sankyo
  • Bayer
  • Tide Pharmaceutical
  • Iroko Pharmaceuticals
  • Horizon Pharma
  • Astellas Pharma
  • Almatica Pharma
  • Abiogen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Spine Osteoarthritis Pain Drug Market by Type
  3. 1.2.1 Global Spine Osteoarthritis Pain Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 External
  6. 1.2.4 Oral
  7. 1.3 Spine Osteoarthritis Pain Drug Market by Application
  8. 1.3.1 Global Spine Osteoarthritis Pain Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Care
  10. 1.3.3 Personal Care
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Spine Osteoarthritis Pain Drug Market Dynamics
  1. 2.1 Spine Osteoarthritis Pain Drug Industry Trends
  2. 2.2 Spine Osteoarthritis Pain Drug Industry Drivers
  3. 2.3 Spine Osteoarthritis Pain Drug Industry Opportunities and Challenges
  4. 2.4 Spine Osteoarthritis Pain Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Spine Osteoarthritis Pain Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Spine Osteoarthritis Pain Drug Revenue by Region
  3. 3.2.1 Global Spine Osteoarthritis Pain Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Spine Osteoarthritis Pain Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Spine Osteoarthritis Pain Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Spine Osteoarthritis Pain Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Spine Osteoarthritis Pain Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Spine Osteoarthritis Pain Drug Sales by Region
  9. 3.4.1 Global Spine Osteoarthritis Pain Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Spine Osteoarthritis Pain Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Spine Osteoarthritis Pain Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Spine Osteoarthritis Pain Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Spine Osteoarthritis Pain Drug Revenue by Manufacturers
  2. 4.1.1 Global Spine Osteoarthritis Pain Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Spine Osteoarthritis Pain Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Spine Osteoarthritis Pain Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Spine Osteoarthritis Pain Drug Sales by Manufacturers
  6. 4.2.1 Global Spine Osteoarthritis Pain Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Spine Osteoarthritis Pain Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Spine Osteoarthritis Pain Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Spine Osteoarthritis Pain Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Spine Osteoarthritis Pain Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Spine Osteoarthritis Pain Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Spine Osteoarthritis Pain Drug Manufacturers, Product Type & Application
  13. 4.7 Global Spine Osteoarthritis Pain Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Spine Osteoarthritis Pain Drug Market CR5 and HHI
  16. 4.8.2 2025 Spine Osteoarthritis Pain Drug Tier 1, Tier 2, and Tier 3
5 Spine Osteoarthritis Pain Drug Market by Type
  1. 5.1 Global Spine Osteoarthritis Pain Drug Revenue by Type
  2. 5.1.1 Global Spine Osteoarthritis Pain Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Spine Osteoarthritis Pain Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Spine Osteoarthritis Pain Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Spine Osteoarthritis Pain Drug Sales by Type
  6. 5.2.1 Global Spine Osteoarthritis Pain Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Spine Osteoarthritis Pain Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Spine Osteoarthritis Pain Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Spine Osteoarthritis Pain Drug Price by Type
6 Spine Osteoarthritis Pain Drug Market by Application
  1. 6.1 Global Spine Osteoarthritis Pain Drug Revenue by Application
  2. 6.1.1 Global Spine Osteoarthritis Pain Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Spine Osteoarthritis Pain Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Spine Osteoarthritis Pain Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Spine Osteoarthritis Pain Drug Sales by Application
  6. 6.2.1 Global Spine Osteoarthritis Pain Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Spine Osteoarthritis Pain Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Spine Osteoarthritis Pain Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Spine Osteoarthritis Pain Drug Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Spine Osteoarthritis Pain Drug Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 TEVA
  8. 7.2.1 TEVA Company Information
  9. 7.2.2 TEVA Business Overview
  10. 7.2.3 TEVA Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TEVA Spine Osteoarthritis Pain Drug Product Portfolio
  12. 7.2.5 TEVA Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Spine Osteoarthritis Pain Drug Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson and Johnson
  20. 7.4.1 Johnson and Johnson Company Information
  21. 7.4.2 Johnson and Johnson Business Overview
  22. 7.4.3 Johnson and Johnson Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson and Johnson Spine Osteoarthritis Pain Drug Product Portfolio
  24. 7.4.5 Johnson and Johnson Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Spine Osteoarthritis Pain Drug Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Mylan
  32. 7.6.1 Mylan Company Information
  33. 7.6.2 Mylan Business Overview
  34. 7.6.3 Mylan Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mylan Spine Osteoarthritis Pain Drug Product Portfolio
  36. 7.6.5 Mylan Recent Developments
  37. 7.7 Eli Lilly
  38. 7.7.1 Eli Lilly Company Information
  39. 7.7.2 Eli Lilly Business Overview
  40. 7.7.3 Eli Lilly Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly Spine Osteoarthritis Pain Drug Product Portfolio
  42. 7.7.5 Eli Lilly Recent Developments
  43. 7.8 Hengrui Pharmaceutical
  44. 7.8.1 Hengrui Pharmaceutical Company Information
  45. 7.8.2 Hengrui Pharmaceutical Business Overview
  46. 7.8.3 Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Product Portfolio
  48. 7.8.5 Hengrui Pharmaceutical Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Spine Osteoarthritis Pain Drug Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Spine Osteoarthritis Pain Drug Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Daiichi Sankyo
  62. 7.11.1 Daiichi Sankyo Company Information
  63. 7.11.2 Daiichi Sankyo Business Overview
  64. 7.11.3 Daiichi Sankyo Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Daiichi Sankyo Spine Osteoarthritis Pain Drug Product Portfolio
  66. 7.11.5 Daiichi Sankyo Recent Developments
  67. 7.12 Bayer
  68. 7.12.1 Bayer Company Information
  69. 7.12.2 Bayer Business Overview
  70. 7.12.3 Bayer Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Spine Osteoarthritis Pain Drug Product Portfolio
  72. 7.12.5 Bayer Recent Developments
  73. 7.13 Tide Pharmaceutical
  74. 7.13.1 Tide Pharmaceutical Company Information
  75. 7.13.2 Tide Pharmaceutical Business Overview
  76. 7.13.3 Tide Pharmaceutical Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Tide Pharmaceutical Spine Osteoarthritis Pain Drug Product Portfolio
  78. 7.13.5 Tide Pharmaceutical Recent Developments
  79. 7.14 Iroko Pharmaceuticals
  80. 7.14.1 Iroko Pharmaceuticals Company Information
  81. 7.14.2 Iroko Pharmaceuticals Business Overview
  82. 7.14.3 Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Product Portfolio
  84. 7.14.5 Iroko Pharmaceuticals Recent Developments
  85. 7.15 Horizon Pharma
  86. 7.15.1 Horizon Pharma Company Information
  87. 7.15.2 Horizon Pharma Business Overview
  88. 7.15.3 Horizon Pharma Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Horizon Pharma Spine Osteoarthritis Pain Drug Product Portfolio
  90. 7.15.5 Horizon Pharma Recent Developments
  91. 7.16 Astellas Pharma
  92. 7.16.1 Astellas Pharma Company Information
  93. 7.16.2 Astellas Pharma Business Overview
  94. 7.16.3 Astellas Pharma Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Astellas Pharma Spine Osteoarthritis Pain Drug Product Portfolio
  96. 7.16.5 Astellas Pharma Recent Developments
  97. 7.17 Almatica Pharma
  98. 7.17.1 Almatica Pharma Company Information
  99. 7.17.2 Almatica Pharma Business Overview
  100. 7.17.3 Almatica Pharma Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Almatica Pharma Spine Osteoarthritis Pain Drug Product Portfolio
  102. 7.17.5 Almatica Pharma Recent Developments
  103. 7.18 Abiogen Pharma
  104. 7.18.1 Abiogen Pharma Company Information
  105. 7.18.2 Abiogen Pharma Business Overview
  106. 7.18.3 Abiogen Pharma Spine Osteoarthritis Pain Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Abiogen Pharma Spine Osteoarthritis Pain Drug Product Portfolio
  108. 7.18.5 Abiogen Pharma Recent Developments
8 North America
  1. 8.1 North America Spine Osteoarthritis Pain Drug Market Size by Type
  2. 8.1.1 North America Spine Osteoarthritis Pain Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Spine Osteoarthritis Pain Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Spine Osteoarthritis Pain Drug Price by Type (2021-2032)
  5. 8.2 North America Spine Osteoarthritis Pain Drug Market Size by Application
  6. 8.2.1 North America Spine Osteoarthritis Pain Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Spine Osteoarthritis Pain Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Spine Osteoarthritis Pain Drug Price by Application (2021-2032)
  9. 8.3 North America Spine Osteoarthritis Pain Drug Market Size by Country
  10. 8.3.1 North America Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Spine Osteoarthritis Pain Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Spine Osteoarthritis Pain Drug Market Size by Type
  2. 9.1.1 Europe Spine Osteoarthritis Pain Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Spine Osteoarthritis Pain Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Spine Osteoarthritis Pain Drug Price by Type (2021-2032)
  5. 9.2 Europe Spine Osteoarthritis Pain Drug Market Size by Application
  6. 9.2.1 Europe Spine Osteoarthritis Pain Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Spine Osteoarthritis Pain Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Spine Osteoarthritis Pain Drug Price by Application (2021-2032)
  9. 9.3 Europe Spine Osteoarthritis Pain Drug Market Size by Country
  10. 9.3.1 Europe Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Spine Osteoarthritis Pain Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Spine Osteoarthritis Pain Drug Market Size by Type
  2. 10.1.1 China Spine Osteoarthritis Pain Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Spine Osteoarthritis Pain Drug Sales by Type (2021-2032)
  4. 10.1.3 China Spine Osteoarthritis Pain Drug Price by Type (2021-2032)
  5. 10.2 China Spine Osteoarthritis Pain Drug Market Size by Application
  6. 10.2.1 China Spine Osteoarthritis Pain Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Spine Osteoarthritis Pain Drug Sales by Application (2021-2032)
  8. 10.2.3 China Spine Osteoarthritis Pain Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Spine Osteoarthritis Pain Drug Market Size by Type
  2. 11.1.1 Asia Spine Osteoarthritis Pain Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Spine Osteoarthritis Pain Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Spine Osteoarthritis Pain Drug Price by Type (2021-2032)
  5. 11.2 Asia Spine Osteoarthritis Pain Drug Market Size by Application
  6. 11.2.1 Asia Spine Osteoarthritis Pain Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Spine Osteoarthritis Pain Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Spine Osteoarthritis Pain Drug Price by Application (2021-2032)
  9. 11.3 Asia Spine Osteoarthritis Pain Drug Market Size by Country
  10. 11.3.1 Asia Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Spine Osteoarthritis Pain Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Spine Osteoarthritis Pain Drug Market Size by Type
  2. 12.1.1 SAMEA Spine Osteoarthritis Pain Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Spine Osteoarthritis Pain Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Spine Osteoarthritis Pain Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Spine Osteoarthritis Pain Drug Market Size by Application
  6. 12.2.1 SAMEA Spine Osteoarthritis Pain Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Spine Osteoarthritis Pain Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Spine Osteoarthritis Pain Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Spine Osteoarthritis Pain Drug Market Size by Country
  10. 12.3.1 SAMEA Spine Osteoarthritis Pain Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Spine Osteoarthritis Pain Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Spine Osteoarthritis Pain Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Spine Osteoarthritis Pain Drug Value Chain Analysis
  2. 13.1.1 Spine Osteoarthritis Pain Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Spine Osteoarthritis Pain Drug Production Mode & Process
  6. 13.2 Spine Osteoarthritis Pain Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Spine Osteoarthritis Pain Drug Distributors
  9. 13.2.3 Spine Osteoarthritis Pain Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst